Login to Your Account



Clinic Roundup


Friday, April 26, 2013

Medgenics Inc., of San Francisco, said there have not been any procedure- or drug-related serious adverse events in the first four patients treated in the Phase IIa trial in Israel of Epodure biopumps for anemia in those on dialysis with end-stage renal disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription